Author:
Liu Yuan,Qi Manli,Hou Shuping,Shao Lili,Zhang Junyan,Li Yan,Liu Quanzhong
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy;Khan;BMJ Open,2015
2. Epidemiology of lung cancer;Alberg;Chest,2003
3. Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors;Chong;Lung Cancer,2014
4. Treatment of advanced non small cell lung cancer;Bareschino;J Thorac Dis,2011
5. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration;Wedge;Cancer Res,2002
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献